FDA Clearance Tracker · P100044-S006
PROPEL MINI SINUS IMPLANTS
Last checked: Nov 20, 2026Latest source record: Jun 10, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jun 10, 2013
Approved
Time to decision
166 days
Received Dec 26, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100044-S006
- Device name
- PROPEL MINI SINUS IMPLANTS
- Applicant
- Intersect Ent.
- Applicant location
- Menlo Park, CA
- Received
- Dec 26, 2012
- Decided
- Jun 10, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100044
Device type
- Device type
- Drug-eluting sinus stent (OWO)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE AT INTERSECT ENT, MENLO PARK, CALIFORNIA.
Source documents
Other decisions for Intersect Ent.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VenSure LightGuide510(k)
K212774 · Decided Feb 4, 2022 · 156 days after receipt
Device type: Instrument, Ent Manual Surgical (LRC) · Otolaryngology (ENT)
- PROPEL CONTOUR SINUS IMPLANTPMA supplement
P100044-S023 · Decided Feb 23, 2017 · 206 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S018 · Decided Mar 23, 2016 · 180 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.